Australia markets closed

NLS Pharmaceutics AG (NLSPW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.0311-0.0089 (-22.25%)
At close: 04:00PM EDT
0.0598 +0.03 (+92.28%)
After hours: 07:08PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,908
5,908
8,977
5,919
99.58
Selling general and administrative
5,899
5,899
6,506
5,941
2,200
Total operating expenses
11,807
11,807
15,482
11,861
2,299
Operating income or loss
-11,807
-11,807
-15,482
-11,861
-2,299
Interest expense
145.153
145.153
100.866
68.134
233.7
Total other income/expenses net
-219.812
-219.812
-912.45
-17.323
-328.365
Income before tax
-12,172
-12,172
-16,496
-11,946
-2,861
Income from continuing operations
-12,172
-12,172
-16,496
-11,946
-2,861
Net income
-12,172
-12,172
-16,496
-11,946
-2,861
Net income available to common shareholders
-12,172
-12,172
-16,496
-11,946
-2,861